tetano
Editor, Senior Moderator
Cureus
. 2021 Jul 31;13(7):e16785.
doi: 10.7759/cureus.16785. eCollection 2021 Jul.
Comparative Evaluation of Nasopharyngeal and Oropharyngeal Swab Based Rapid SARS-CoV-2 Antigen Detection and Real-Time RT-PCR for Diagnosis of COVID-19 in Tertiary Care Hospital
Arpana Singh[SUP] 1 [/SUP], Pratima Gupta[SUP] 1 [/SUP], Yogendra P Mathuria[SUP] 1 [/SUP], Deepjyoti Kalita[SUP] 1 [/SUP], Amber Prasad[SUP] 1 [/SUP], Prasan K Panda[SUP] 2 [/SUP], Yogesh Bahurupi[SUP] 3 [/SUP], Biswajeet Sahoo[SUP] 1 [/SUP], Balram Ji Omar[SUP] 1 [/SUP]
Affiliations
Abstract
Purpose: To assess and compare the diagnostic accuracy of the GenBody COVID-19 Antigen kit (GenBody Inc., Cheonan, South Korea) available in the market with the gold standard reverse transcription-polymerase chain reaction (RT-PCR) assay to detect severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Methods: Nasopharyngeal and oropharyngeal swabs were collected from suspected coronavirus disease 2019 (COVID-19) patients and tested by RT-PCR and GenBody Rapid antigen kit. Performance characteristic of the antigen kit was calculated.
Results: We tested nasopharyngeal swabs and oropharyngeal swabs (n=240). Amongst the 102 positive RT-PCR samples, the rapid antigen test detected 36 as positive, showing an overall sensitivity of 35.3%. All the samples detected positive with the antigen rapid test were also detected positive by RT-PCR.
Conclusion: The performance of the rapid antigen kit was good with respect to high viral load samples, whereas those with lower levels were missed. Unfortunately, the overall low sensitivity of the antigen kit does not allow using it alone as the frontline testing kit for COVID-19 diagnosis.
Keywords: covid 19; rapid antigen test; rdt; rt-pcr; sars cov-2.
. 2021 Jul 31;13(7):e16785.
doi: 10.7759/cureus.16785. eCollection 2021 Jul.
Comparative Evaluation of Nasopharyngeal and Oropharyngeal Swab Based Rapid SARS-CoV-2 Antigen Detection and Real-Time RT-PCR for Diagnosis of COVID-19 in Tertiary Care Hospital
Arpana Singh[SUP] 1 [/SUP], Pratima Gupta[SUP] 1 [/SUP], Yogendra P Mathuria[SUP] 1 [/SUP], Deepjyoti Kalita[SUP] 1 [/SUP], Amber Prasad[SUP] 1 [/SUP], Prasan K Panda[SUP] 2 [/SUP], Yogesh Bahurupi[SUP] 3 [/SUP], Biswajeet Sahoo[SUP] 1 [/SUP], Balram Ji Omar[SUP] 1 [/SUP]
Affiliations
- PMID: 34513392
- PMCID: PMC8405413
- DOI: 10.7759/cureus.16785
Abstract
Purpose: To assess and compare the diagnostic accuracy of the GenBody COVID-19 Antigen kit (GenBody Inc., Cheonan, South Korea) available in the market with the gold standard reverse transcription-polymerase chain reaction (RT-PCR) assay to detect severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Methods: Nasopharyngeal and oropharyngeal swabs were collected from suspected coronavirus disease 2019 (COVID-19) patients and tested by RT-PCR and GenBody Rapid antigen kit. Performance characteristic of the antigen kit was calculated.
Results: We tested nasopharyngeal swabs and oropharyngeal swabs (n=240). Amongst the 102 positive RT-PCR samples, the rapid antigen test detected 36 as positive, showing an overall sensitivity of 35.3%. All the samples detected positive with the antigen rapid test were also detected positive by RT-PCR.
Conclusion: The performance of the rapid antigen kit was good with respect to high viral load samples, whereas those with lower levels were missed. Unfortunately, the overall low sensitivity of the antigen kit does not allow using it alone as the frontline testing kit for COVID-19 diagnosis.
Keywords: covid 19; rapid antigen test; rdt; rt-pcr; sars cov-2.